Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification.
Petter DavikSebastiaan RemmersMattijs ElschotMonique J RoobolTone Frost BathenHelena BertilssonPublished in: BJUI compass (2022)
The ERSPC RCs 3/4 and MRI-ERSPC-RCs can considerably reduce both upfront mpMRI and prostate biopsies with little risk of missing csPCa.